4//SEC Filing
LICHTINGER PEDRO 4
Accession 0001142576-13-000011
CIK 0001142576other
Filed
Apr 9, 8:00 PM ET
Accepted
Apr 10, 9:59 PM ET
Size
14.7 KB
Accession
0001142576-13-000011
Insider Transaction Report
Form 4
LICHTINGER PEDRO
CEO and President
Transactions
- Sale
Common stock
2013-04-08$14.73/sh−90,000$1,325,538→ 104,078 total - Exercise/Conversion
Common stock
2013-04-08$11.41/sh+58,000$661,780→ 162,078 total - Sale
Common stock
2013-04-08$14.63/sh−58,000$848,453→ 194,078 total - Exercise/Conversion
Stock option (right to buy)
2013-04-08−58,000→ 0 totalExercise: $11.41Exp: 2013-05-26→ Common stock (58,000 underlying) - Exercise/Conversion
Common stock
2013-04-08$13.51/sh+90,000$1,215,900→ 252,078 total - Exercise/Conversion
Stock option (right to buy)
2013-04-08−90,000→ 0 totalExercise: $13.51Exp: 2013-05-26→ Common stock (90,000 underlying)
Footnotes (3)
- [F1]On January 26, 2011, the reporting person was granted an option to purchase 58,000 shares of common stock. 1/4 of the shares subject to the option vested on January 1, 2012. Thereafter, the remaining shares subject to the option were scheduled to vest and become exercisable in 36 equal montly installments subject to the reporting person continuing to be service provider on each such date. At the time the reporting person's service was terminated in February 2013, the option: (i) had vested as to 30,208 shares; and (ii) was accelerated as to 27,792 shares in accordance with the reporting person's separation agreement.
- [F2]On February 7, 2012, the reporting person was granted an option to purchase 120,000 shares of common stock. 1/4 of the shares subject to the option vested on February 7, 2013. Thereafter, the remaining shares subject to the option were scheduled to vest and become exercisable in 36 monthly installments subject to the reporting person continuing to be service provider on each such date. At the time the reporting person's service was terminated in February 2013, the option: (i) had vested as to 30,000 shares; (ii) was accelerated as to 60,000 shares in accordance with the reporting person's separation agreement; and (iii) was cancelled as to the remaining 30,000 shares.
- [F3]Without admitting any legal obligation, the reporting person has agreed to remit to the Company appropriate profits realized for purposes of Section 16(b) of the Securities and Exchange Act of 1934, as amended.
Documents
Issuer
OPTIMER PHARMACEUTICALS INC
CIK 0001142576
Entity typeother
Related Parties
1- filerCIK 0001470741
Filing Metadata
- Form type
- 4
- Filed
- Apr 9, 8:00 PM ET
- Accepted
- Apr 10, 9:59 PM ET
- Size
- 14.7 KB